OTCMKTS:OPTHF Optimi Health (OPTHF) Stock Price, News & Analysis → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free OPTHF Stock Alerts $0.25 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.24▼$0.2750-Day Range$0.15▼$0.2552-Week Range$0.11▼$0.43Volume3,721 shsAverage Volume14,322 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Optimi Health alerts: Email Address Ad DTIWhat is the 72-Hour Profit Surge?One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…Click here now to get all the details. About Optimi Health Stock (OTCMKTS:OPTHF)Optimi Health Corp. engages in the research, cultivation, processing, extraction, and distribution of psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada and internationally. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of fungi varieties, including Lion's Mane, Chaga, Reishi, Turkey Tail, and Cordyceps. It sells its products through www.optimilife.com, an e-commerce website platform; and Amazon marketplace, and distributors/brokers. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is based in Garibaldi Highlands, Canada.Read More OPTHF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OPTHF Stock News HeadlinesApril 23, 2024 | globenewswire.comOptimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and ResearchApril 15, 2024 | finance.yahoo.comOptimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)April 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 11, 2024 | uk.investing.comOptimi Health Signs Psilocybin Supply Agreement With New Zealand-Based MÄ tai Medical Research InstituteApril 9, 2024 | benzinga.comOptimi To Supply Psilocybin For New Zealand's Mātai Medical Research InstituteApril 9, 2024 | globenewswire.comOptimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research InstituteApril 4, 2024 | finance.yahoo.comEarly Warning Press Release in Accordance with National Instrument 62-103April 2, 2024 | globenewswire.comOptimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin ExtractApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.March 28, 2024 | globenewswire.comOptimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development ConferenceMarch 26, 2024 | msn.comTwo Top Biotechs Forge MDMA Supply Deals For An Expanding Research FieldMarch 26, 2024 | globenewswire.comOptimi Health to Supply MDMA for Psychedelic Research at Tel Aviv UniversityMarch 18, 2024 | ca.finance.yahoo.comOil prices build on last week's gains as supply risks riseFebruary 28, 2024 | globenewswire.comOptimi Announces Closing of First Tranche of Non-Brokered Private PlacementFebruary 18, 2024 | finance.yahoo.comOptimi Health Corp. (OPTHF)February 12, 2024 | finance.yahoo.comOptimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production VideoFebruary 8, 2024 | finance.yahoo.comOptimi Announces Non-Brokered Private PlacementFebruary 6, 2024 | finance.yahoo.comOptimi Health To Host MDMA Educational Quality Assurance Webinar For Clinicians And PractitionersJanuary 30, 2024 | benzinga.comOptimi Health Stock (OTC:OPTHF) Dividends: History, Yield and DatesJanuary 19, 2024 | finance.yahoo.comOptimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer’s LicenceJanuary 3, 2024 | finance.yahoo.comOptimi Health Granted Precursor Licence To Formulate MDMA And Completes Encapsulation Of 40mg And 60mg Dosage FormatsDecember 7, 2023 | finance.yahoo.comOptimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply AgreementNovember 28, 2023 | finance.yahoo.comOptimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability TestingNovember 23, 2023 | morningstar.comOptimi Health Corp OPTHFNovember 10, 2023 | finanznachrichten.deOptimi Health Corp.: Optimi Health Resolves DisputeNovember 10, 2023 | finance.yahoo.comOptimi Health Resolves DisputeNovember 7, 2023 | finance.yahoo.comOptimi Health Welcomes Dr. Preston A. Chase as New Chief Science OfficerSee More Headlines Receive OPTHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Optimi Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:OPTHF CUSIPN/A CIKN/A Webwww.optimihealth.ca Phone778-761-4551FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. John James Wilson (Age 34)Co-Founder & Non-Executive Chairman Comp: $78.75kMr. William J. Ciprick (Age 47)Chief Executive Officer Comp: $254.05kMr. Bryan Edward Safarik (Age 39)Co-Founder, COO & Director Comp: $95.27kMr. Dane Stevens (Age 34)Co-Founder, Chief Marketing Officer & Director Comp: $57.34kMr. Jacob Safarik (Age 37)Co-Founder, CFO & Director Comp: $57.34kDr. Preston A. ChaseChief Science OfficerLaura ChowDirector of Products & SalesMs. Ann LittleHuman Resources ManagerMs. Leah Hodges (Age 40)Corporate Secretary More ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors OPTHF Stock Analysis - Frequently Asked Questions How have OPTHF shares performed in 2024? Optimi Health's stock was trading at $0.1865 at the beginning of 2024. Since then, OPTHF stock has increased by 31.9% and is now trading at $0.2460. View the best growth stocks for 2024 here. Are investors shorting Optimi Health? Optimi Health saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 1,900 shares, a drop of 83.8% from the March 31st total of 11,700 shares. Based on an average daily volume of 17,000 shares, the short-interest ratio is presently 0.1 days. View Optimi Health's Short Interest. How do I buy shares of Optimi Health? Shares of OPTHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:OPTHF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Optimi Health Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
